In press future contents
Articles accepted for publication and currently in press. In this page a list of future contents of CER.
Full Papers
CER18966
Evaluating the metabolic score for insulin resistance in patients with systemic lupus erythematosus
A. Aznar-Esquivel, M. Hernández-González, M. García-González, F. Gómez-Bernal, J.C. Quevedo-Abeledo, C. Almeida-Santiago, A. Molina-Tercero, E. Heras-Recuero, A. De vera-González, A. González-Delgado, B. Tejera-Segura, M.Á. González-Gay, I. Ferraz-Amaro
DOI: https://doi.org/10.55563/clinexprheumatol/m42g9r
A. Aznar-Esquivel, M. Hernández-González, M. García-González, F. Gómez-Bernal, J.C. Quevedo-Abeledo, C. Almeida-Santiago, A. Molina-Tercero, E. Heras-Recuero, A. De vera-González, A. González-Delgado, B. Tejera-Segura, M.Á. González-Gay, I. Ferraz-Amaro
DOI: https://doi.org/10.55563/clinexprheumatol/m42g9r
CER18916
Three-year follow-up from a randomised controlled trial of a single intra-articular polyacrylamide hydrogel injection in subjects with knee osteoarthritis
H. Bliddal, J. Beier, A. Hartkopp, P.G. Conaghan, M. Henriksen
DOI: https://doi.org/10.55563/clinexprheumatol/5lofry
H. Bliddal, J. Beier, A. Hartkopp, P.G. Conaghan, M. Henriksen
DOI: https://doi.org/10.55563/clinexprheumatol/5lofry
CER18886
Free to view
High sensitivity measurement of circulating interferon proteins in systemic lupus erythematosus
Y.-J. Huang, C.M. Bottomley, R.T. Maughan, A. Field, G.H. Leung, L. Lightstone, T.D. Cairns, T. Turner-Stokes, M.B. Condon, J.E. Peters, M. Botto, M.C. Pickering
DOI: https://doi.org/10.55563/clinexprheumatol/lyd5es
Y.-J. Huang, C.M. Bottomley, R.T. Maughan, A. Field, G.H. Leung, L. Lightstone, T.D. Cairns, T. Turner-Stokes, M.B. Condon, J.E. Peters, M. Botto, M.C. Pickering
DOI: https://doi.org/10.55563/clinexprheumatol/lyd5es
CER18890
Free to view
Peripheral blood immunophenotypic diversity in patients with anti-MDA5+ dermatomyositis and its impact on prognosis
Y. Zhang, R. Liu, W. Hu, T. Li, T. Li, W. Guan, L. Zhang, Y. He, C. Lian, J. Sun, S. Liu, P. Zhang
DOI: https://doi.org/10.55563/clinexprheumatol/qumg88
Y. Zhang, R. Liu, W. Hu, T. Li, T. Li, W. Guan, L. Zhang, Y. He, C. Lian, J. Sun, S. Liu, P. Zhang
DOI: https://doi.org/10.55563/clinexprheumatol/qumg88
CER18899
Free to view
Tracheobronchial stenosis in patients with granulomatosis with polyangiitis: histopathological findings and long-term outcome
L. Linde, M. Faurschou, S.B. Krintel, B. Baslund
DOI: https://doi.org/10.55563/clinexprheumatol/xqt7su
L. Linde, M. Faurschou, S.B. Krintel, B. Baslund
DOI: https://doi.org/10.55563/clinexprheumatol/xqt7su
CER18913
SHP2 inhibitor mitigated renal tubular epithelial cell injury in lupus nephritis via ERK/NF-κB pathway
Y. Chen, S. Wang, S. Tan, T. Jiang, X. Li, G. Yao, L. Sun
DOI: https://doi.org/10.55563/clinexprheumatol/csqb0j
Y. Chen, S. Wang, S. Tan, T. Jiang, X. Li, G. Yao, L. Sun
DOI: https://doi.org/10.55563/clinexprheumatol/csqb0j
CER18920
Free to view
Effectiveness of SARS-CoV-2 vaccination program in systemic sclerosis patients treated by autologous haematopoietic stem cell transplantation: a comparative study on behalf of MATHEC-SFGM-TC group
L. Biard, G. Pugnet, C. Cacciatore, P.H. Prata, B. Crichi, F. Urbain, I. Munia, P. Lansiaux, C. Le Maignan, D. Farge
DOI: https://doi.org/10.55563/clinexprheumatol/8o94lv
L. Biard, G. Pugnet, C. Cacciatore, P.H. Prata, B. Crichi, F. Urbain, I. Munia, P. Lansiaux, C. Le Maignan, D. Farge
DOI: https://doi.org/10.55563/clinexprheumatol/8o94lv
CER18935
The application value of peripheral plasmablasts in the assessment of disease activity and treatment response in systemic lupus erythematosus.
L. Wan, J. Guo, A. Sun, H. Chen, B. Hu, C. Liu
DOI: https://doi.org/10.55563/clinexprheumatol/xsjjih
L. Wan, J. Guo, A. Sun, H. Chen, B. Hu, C. Liu
DOI: https://doi.org/10.55563/clinexprheumatol/xsjjih
CER18944
Free to view
Acute activation of rat dorsal root ganglion neurons and their satellite glial cells by the serum of patients suffering from fibromyalgia
F. Mercado, A. Almanza, P. Segura-Chama, V. Galindo-Avendaño, L.-A. Martínez-Martínez, M. Martínez-Lavín
DOI: https://doi.org/10.55563/clinexprheumatol/g3vzz3
F. Mercado, A. Almanza, P. Segura-Chama, V. Galindo-Avendaño, L.-A. Martínez-Martínez, M. Martínez-Lavín
DOI: https://doi.org/10.55563/clinexprheumatol/g3vzz3
CER19455
Altered gut microbiota and host pathways in obesity-related knee osteoarthritis
J. Huang, M. Liu, H. Zhang, G. Sun, A. Furey, P. Rahman, G. Zhai
DOI: https://doi.org/10.55563/clinexprheumatol/ksopba
J. Huang, M. Liu, H. Zhang, G. Sun, A. Furey, P. Rahman, G. Zhai
DOI: https://doi.org/10.55563/clinexprheumatol/ksopba
CER18959
Free to view
Risk of major cardiovascular events in patients with systemic sclerosis: insights into an underestimated concern from a systematic literature review and meta-analysis
G. Pellegrino, D. Mohammad Reza Beigi, A. Varvaro, M. Arese, V. Riccieri, P. Sarzi-Puttini
DOI: https://doi.org/10.55563/clinexprheumatol/6pstix
G. Pellegrino, D. Mohammad Reza Beigi, A. Varvaro, M. Arese, V. Riccieri, P. Sarzi-Puttini
DOI: https://doi.org/10.55563/clinexprheumatol/6pstix
CER18788
Free to view
Modification of cardiovascular risk factors after viscosupplementation with hyaluronic acid in patients with symptomatic hip and knee osteoarthritis
A.M. García-Bravo, M.Á. Ruiz-Fernández, A. Taboada Vázquez, A. Vizcaíno-Arzola, O. Del Rey Echevarría, M. Rufino-Navarro, L. Pérez-Méndez, F.J. De león-García
DOI: https://doi.org/10.55563/clinexprheumatol/tsa1u8
A.M. García-Bravo, M.Á. Ruiz-Fernández, A. Taboada Vázquez, A. Vizcaíno-Arzola, O. Del Rey Echevarría, M. Rufino-Navarro, L. Pérez-Méndez, F.J. De león-García
DOI: https://doi.org/10.55563/clinexprheumatol/tsa1u8
CER18985
Clinical characteristics and prognostic analysis of concurrent Pneumocystis jirovecii pneumonia in patients with connective tissue diseases: a retrospective study
Y. Shi, R. Chen, H. Sun, K. Xu, Z. Li, M. Wang, C. Shao, H. Huang
DOI: https://doi.org/10.55563/clinexprheumatol/yyd4gm
Y. Shi, R. Chen, H. Sun, K. Xu, Z. Li, M. Wang, C. Shao, H. Huang
DOI: https://doi.org/10.55563/clinexprheumatol/yyd4gm
CER18994
Exploring the comorbidity mechanism of rheumatoid arthritis and systemic lupus erythematosus through transcriptomics and conducting experimental validation
M. Shen, C. You
DOI: https://doi.org/10.55563/clinexprheumatol/1xlydo
M. Shen, C. You
DOI: https://doi.org/10.55563/clinexprheumatol/1xlydo
CER19004
Giant cell arteritis in clinical practice: beyond GiACTA
F. Regola, J. Mora, M. Riva, G. Fontana, A. Gatti, I. Cavazzana, F. Franceschini, P. Toniati
DOI: https://doi.org/10.55563/clinexprheumatol/7vcti0
F. Regola, J. Mora, M. Riva, G. Fontana, A. Gatti, I. Cavazzana, F. Franceschini, P. Toniati
DOI: https://doi.org/10.55563/clinexprheumatol/7vcti0
CER19007
Free to view
The MicroIBioM study: the gut microbiome in inclusion body myositis
M. Winkler, W. Seel, C. Kornblum, M.-C. Simon, J. Reimann
DOI: https://doi.org/10.55563/clinexprheumatol/1b8sv1
M. Winkler, W. Seel, C. Kornblum, M.-C. Simon, J. Reimann
DOI: https://doi.org/10.55563/clinexprheumatol/1b8sv1
CER19019
Free to view
The Refractory DermatoMyositis Index (ReDMI): a clinical tool to predict refractory disease in patients with dermatomyositis
Y. Reyna-Juárez, N.R. Mejía-Domínguez, M.J. Ostos-Prado, B. Alcalá-Carmona, J.T. Balderas-Miranda, A. Gaytán, A. Hernández-López, C.A. Núñez-Álvarez, M.E. Baños-Laredo, M.L. Domínguez-López, K. Santana De Anda, D. Gómez-Martín, J. Torres-Ruiz
DOI: https://doi.org/10.55563/clinexprheumatol/k77xaj
Y. Reyna-Juárez, N.R. Mejía-Domínguez, M.J. Ostos-Prado, B. Alcalá-Carmona, J.T. Balderas-Miranda, A. Gaytán, A. Hernández-López, C.A. Núñez-Álvarez, M.E. Baños-Laredo, M.L. Domínguez-López, K. Santana De Anda, D. Gómez-Martín, J. Torres-Ruiz
DOI: https://doi.org/10.55563/clinexprheumatol/k77xaj
CER19029
Belimumab modulates type I interferon signalling in the treatment of systemic lupus erythematosus
T. Xun, Q. Ding, Y. Ye, X. Yang, L. Mo
DOI: https://doi.org/10.55563/clinexprheumatol/03t59o
T. Xun, Q. Ding, Y. Ye, X. Yang, L. Mo
DOI: https://doi.org/10.55563/clinexprheumatol/03t59o
CER19038
Treatment sequences and lines of therapy in rheumatoid arthritis: a real-world evaluation of retention and effectiveness
M. Movahedi, B. Kuriya, A. Cesta, X. Li, S.Z. Aydin, C. Bombardier, P. Akhavan
on behalf of Ontario Best Practices Initiative (OBRI) Investigators, UHN, Toronto, Canada.
DOI: https://doi.org/10.55563/clinexprheumatol/y1vbr1
M. Movahedi, B. Kuriya, A. Cesta, X. Li, S.Z. Aydin, C. Bombardier, P. Akhavan
on behalf of Ontario Best Practices Initiative (OBRI) Investigators, UHN, Toronto, Canada.
DOI: https://doi.org/10.55563/clinexprheumatol/y1vbr1
CER19044
Long-term outcome and clinicopathological characteristics of propylthiouracil-induced ANCA-associated glomerulonephritis: a case-control study
D. Wu, R. Zhang, X. Wang, Y. Rong, Z. Liu, W. Hu, J. Wang, H. Zhang
DOI: https://doi.org/10.55563/clinexprheumatol/johu1h
D. Wu, R. Zhang, X. Wang, Y. Rong, Z. Liu, W. Hu, J. Wang, H. Zhang
DOI: https://doi.org/10.55563/clinexprheumatol/johu1h
CER18958
Cardiac strain in patients on Janus Kinase inhibitors for rheumatic diseases: a 1-year echocardiographic study
N. Kougkas, E. Skouvaklidou, K. Tsafis, D. Deligeorgakis, V. Skepastianos, C. Adamichou, E. Papadimitriou, A. Mpitouli, M. Boutel, F. Dimitriadis, G. Spagos, I. Zarifis, T. Dimitroulas, A. Tsaousidis
DOI: https://doi.org/10.55563/clinexprheumatol/al5kv6
N. Kougkas, E. Skouvaklidou, K. Tsafis, D. Deligeorgakis, V. Skepastianos, C. Adamichou, E. Papadimitriou, A. Mpitouli, M. Boutel, F. Dimitriadis, G. Spagos, I. Zarifis, T. Dimitroulas, A. Tsaousidis
DOI: https://doi.org/10.55563/clinexprheumatol/al5kv6
CER18631
Free to view
Pneumocystis jirovecii pneumonia in anti-MDA5-positive dermatomyositis: characterisation, risk factors and prognosis
L. Yang, Q. Yang, J. Li, L. Zhang, S. Liu, C. Lian
DOI: https://doi.org/10.55563/clinexprheumatol/hpx173
L. Yang, Q. Yang, J. Li, L. Zhang, S. Liu, C. Lian
DOI: https://doi.org/10.55563/clinexprheumatol/hpx173
CER18292
Free to view
Treatment outcomes in 63 cases of juvenile dermatomyositis-associated calcinosis
B.Y. Yi, D.M. Wahezi, L. Covert, K. Ardalan, J. Hui-Yuen, N. Vasquez-Canizares, D.M. Mosa, M. Jones, C. Correll, A. Begezda, S. Shenoi, E.Y. Wu, L.K. Kovalick, W.B. Lapin, S.E. Tarvin, M.S. Oliver, M.M. Rodriguez, I. Marmor, K.W. Baszis, A.J. Taxter, A.C. Hanson, C.S. Crowson, A.B. Orandi
for the CARRA Juvenile Dermatomyositis, Calcinosis Subcommittee
DOI: https://doi.org/10.55563/clinexprheumatol/35pbbq
B.Y. Yi, D.M. Wahezi, L. Covert, K. Ardalan, J. Hui-Yuen, N. Vasquez-Canizares, D.M. Mosa, M. Jones, C. Correll, A. Begezda, S. Shenoi, E.Y. Wu, L.K. Kovalick, W.B. Lapin, S.E. Tarvin, M.S. Oliver, M.M. Rodriguez, I. Marmor, K.W. Baszis, A.J. Taxter, A.C. Hanson, C.S. Crowson, A.B. Orandi
for the CARRA Juvenile Dermatomyositis, Calcinosis Subcommittee
DOI: https://doi.org/10.55563/clinexprheumatol/35pbbq
CER18299
Free to view
GITR/GITRL interaction promotes the expansion of T helper 9 and T helper 17 in psoriatic arthritis
L. La Barbera, C. Rizzo, M. Lo Pizzo, D. Di Liberto, M.P. La Manna, L. Mohammadnezhad, F. Camarda, G. Sireci, F. Ciccia, G. Guggino
DOI: https://doi.org/10.55563/clinexprheumatol/31hjvf
L. La Barbera, C. Rizzo, M. Lo Pizzo, D. Di Liberto, M.P. La Manna, L. Mohammadnezhad, F. Camarda, G. Sireci, F. Ciccia, G. Guggino
DOI: https://doi.org/10.55563/clinexprheumatol/31hjvf
CER18354
Application of lupus comprehensive disease control in newly diagnosed systemic lupus erythematosus patients: results from the Italian multicentre Early Lupus Project inception cohort
F. Ceccarelli, M. Piga, F.R. Spinelli, I. Prevete, A. Cauli, F. Iannone, L. Coladonato, M. Govoni, A. Bortoluzzi, M. Mosca, C. Tani, A. Doria, L. Iaccarino, F. Franceschini, M. Fredi, B. Frediani, F. Bellisai, D. Rozza, A. Zanetti, G. Carrara, C.A. Scirè, G.D. Sebastiani, F. Conti
on behalf of the study group on Early SLE of the Italian Society of Rheumatology
DOI: https://doi.org/10.55563/clinexprheumatol/dagoie
F. Ceccarelli, M. Piga, F.R. Spinelli, I. Prevete, A. Cauli, F. Iannone, L. Coladonato, M. Govoni, A. Bortoluzzi, M. Mosca, C. Tani, A. Doria, L. Iaccarino, F. Franceschini, M. Fredi, B. Frediani, F. Bellisai, D. Rozza, A. Zanetti, G. Carrara, C.A. Scirè, G.D. Sebastiani, F. Conti
on behalf of the study group on Early SLE of the Italian Society of Rheumatology
DOI: https://doi.org/10.55563/clinexprheumatol/dagoie
CER18378
Free to view
Predictors of thrombotic events in patients with idiopathic inflammatory myopathies
S.S. Bae, J. Wang, A. Shahbazian, D. Markovic, Y. Lee, T. De Leon, D. Elashoff, C. Charles-Schoeman
DOI: https://doi.org/10.55563/clinexprheumatol/bj7nq2
S.S. Bae, J. Wang, A. Shahbazian, D. Markovic, Y. Lee, T. De Leon, D. Elashoff, C. Charles-Schoeman
DOI: https://doi.org/10.55563/clinexprheumatol/bj7nq2
CER18415
Free to view
Avacopan with combined cyclophosphamide and rituximab for induction therapy in severe ANCA-associated vasculitis: retrospective observational study of 30 patients in two German referral centres
G. Assmann, E.-B. Adjailia, S. Klapa, K. Von Allwoerden, K. Amann, R. Turkiewicz, J. Radermacher, P. Lamprecht
DOI: https://doi.org/10.55563/clinexprheumatol/7sz0zp
G. Assmann, E.-B. Adjailia, S. Klapa, K. Von Allwoerden, K. Amann, R. Turkiewicz, J. Radermacher, P. Lamprecht
DOI: https://doi.org/10.55563/clinexprheumatol/7sz0zp
CER18417
Efficacy and safety of monoclonal antibody AK111 in the treatment of active ankylosing spondylitis: a randomised, double-blind, placebo-controlled, multicentre phase II clinical study
H. Ye, S. Liu, Y. Mei, J. Gu, M. Yang, L. Zhang, G. Wang, Z. He, F. Wu, Y. Zheng, M. Xia, B. Li, Z. Li
DOI: https://doi.org/10.55563/clinexprheumatol/2t27x9
H. Ye, S. Liu, Y. Mei, J. Gu, M. Yang, L. Zhang, G. Wang, Z. He, F. Wu, Y. Zheng, M. Xia, B. Li, Z. Li
DOI: https://doi.org/10.55563/clinexprheumatol/2t27x9
CER18591
Free to view
Comprehensive magnetic resonance imaging evaluation in a cohort of 145 patients with Takayasu's arteritis. Proposal for a standardised and systematic reporting format
M.E. Soto, G. Meléndez-Ramírez, M.C. Herrera Zarza, A. Meave, M.Á. Cruz-Marmolejo, A. Mendez-Dominguez, J.S. Arias-Fernandez, M.Á. Aguirre-Delfin
DOI: https://doi.org/10.55563/clinexprheumatol/4bmcp0
M.E. Soto, G. Meléndez-Ramírez, M.C. Herrera Zarza, A. Meave, M.Á. Cruz-Marmolejo, A. Mendez-Dominguez, J.S. Arias-Fernandez, M.Á. Aguirre-Delfin
DOI: https://doi.org/10.55563/clinexprheumatol/4bmcp0
CER18602
Free to view
Analysis of clinical features and risk factors for patients with idiopathic inflammatory myopathy complicated by Pneumocystis jirovecii pneumonia
J. Li, W. Huang, F. Ren, L. Luo, D. Chen, D. Huang, J. Zhou, L. Tang
DOI: https://doi.org/10.55563/clinexprheumatol/fpbkc8
J. Li, W. Huang, F. Ren, L. Luo, D. Chen, D. Huang, J. Zhou, L. Tang
DOI: https://doi.org/10.55563/clinexprheumatol/fpbkc8
CER18832
Circulating microRNAs associated with tumour necrosis factor or fibloblast-like synoviocyte predict cartilage damage in early rheumatoid arthritis treated with methotrexate plus adalimumab: a subanalysis of the MIRACLE study
Y. Hosokawa, Y. Yoshida, H. Tamai, S. Hirata, K. Ikeda, T. Miyamoto, H. Taguchi, C.-F. Kuo, K. Shin, K. Izumi, Y. Kondo, H. Yasuoka, M. Kuwana, T. Ishii, H. Kameda, T. Kojima, M. Mori, Y. Sato, W.-C. Tsai, T. Takeuchi, Y. Kaneko
Collaborator/s: Y. Okano, S. Sato, T. Gono, K. Yoshimoto, I.A. Choi, S.-H. Park, M.-Y. Weng, Y.J. Lee, J. Kim, H.J. Baek, P.-N. Hsu, C.-M. Huang, T.-T. Cheng, W.-Y. Sung
the MIRACLE study collaborators
DOI: https://doi.org/10.55563/clinexprheumatol/keymab
Y. Hosokawa, Y. Yoshida, H. Tamai, S. Hirata, K. Ikeda, T. Miyamoto, H. Taguchi, C.-F. Kuo, K. Shin, K. Izumi, Y. Kondo, H. Yasuoka, M. Kuwana, T. Ishii, H. Kameda, T. Kojima, M. Mori, Y. Sato, W.-C. Tsai, T. Takeuchi, Y. Kaneko
Collaborator/s: Y. Okano, S. Sato, T. Gono, K. Yoshimoto, I.A. Choi, S.-H. Park, M.-Y. Weng, Y.J. Lee, J. Kim, H.J. Baek, P.-N. Hsu, C.-M. Huang, T.-T. Cheng, W.-Y. Sung
the MIRACLE study collaborators
DOI: https://doi.org/10.55563/clinexprheumatol/keymab
CER18610
Cardiac involvement in patients with anti-melanoma differentiation-associated gene-5 antibody-positive dermatomyositis
Y. Wang, X. Chen, Z. Huang, Y. Wang, W. Jiang, J. Lei, S. Xie, L. Zhang
DOI: https://doi.org/10.55563/clinexprheumatol/r1f2g9
Y. Wang, X. Chen, Z. Huang, Y. Wang, W. Jiang, J. Lei, S. Xie, L. Zhang
DOI: https://doi.org/10.55563/clinexprheumatol/r1f2g9
CER18823
Predictions of rheumatoid arthritis burden in 204 countries and territories by 2044: based on the Global Burden of Disease Study 2021
W. Zhang, D. Zhuang, H. Lu, Z. Lv, L. Huang, H. Du, J. Chang, M. Xiao, M. Chen, W. Ying, H. Lei, X. Li
DOI: https://doi.org/10.55563/clinexprheumatol/7dijpb
W. Zhang, D. Zhuang, H. Lu, Z. Lv, L. Huang, H. Du, J. Chang, M. Xiao, M. Chen, W. Ying, H. Lei, X. Li
DOI: https://doi.org/10.55563/clinexprheumatol/7dijpb
CER18678
Free to view
Short Form 36 (SF-36) health survey questionnaire in health-related quality of life assessment in patients with inflammatory myopathies
A. Razok, J. Taylor, E. Ritz, K. Wipfler, K. Michaud, D. Saygin
DOI: https://doi.org/10.55563/clinexprheumatol/sbc4v3
A. Razok, J. Taylor, E. Ritz, K. Wipfler, K. Michaud, D. Saygin
DOI: https://doi.org/10.55563/clinexprheumatol/sbc4v3
CER18685
Tofacitinib attenuates IL-6-mediated endothelial tissue factor induction in vitro without affecting platelet aggregation in vivo: mechanistic insights into cardiovascular risk in rheumatoid arthritis
G. Cimmino, D. Mauro, M. Morello, G. Titolo, D. Iacono, G. Forte, A. Salzillo, M. Raimondi, F. Riccio, I. Pantano, G. De Rosa, P. Cirillo, F. Ciccia
DOI: https://doi.org/10.55563/clinexprheumatol/k0fdes
G. Cimmino, D. Mauro, M. Morello, G. Titolo, D. Iacono, G. Forte, A. Salzillo, M. Raimondi, F. Riccio, I. Pantano, G. De Rosa, P. Cirillo, F. Ciccia
DOI: https://doi.org/10.55563/clinexprheumatol/k0fdes
CER18694
Free to view
Rheumatoid factor positivity in granulomatosis with polyangiitis: implications for clinical outcomes and immunological profiles
B. Öz, G. Yamancan, A. Karataş, S. Serdar Koca
DOI: https://doi.org/10.55563/clinexprheumatol/n373g7
B. Öz, G. Yamancan, A. Karataş, S. Serdar Koca
DOI: https://doi.org/10.55563/clinexprheumatol/n373g7
CER18745
Free to view
Clinical phenotypes and long-term outcomes of anti-SRP versus anti-HMGCR immune-mediated necrotising myopathy: a 13-year single-centre study
K.E. Clark, L.M. Clayton, R.G. Thomas, S.G. Kelly, L. Walker, A.S. Herrey, A. Dougan, R.S. Patel, S. Fhadil, T.O. Millner, S. Marino, A. Radunovic
DOI: https://doi.org/10.55563/clinexprheumatol/icqeff
K.E. Clark, L.M. Clayton, R.G. Thomas, S.G. Kelly, L. Walker, A.S. Herrey, A. Dougan, R.S. Patel, S. Fhadil, T.O. Millner, S. Marino, A. Radunovic
DOI: https://doi.org/10.55563/clinexprheumatol/icqeff
CER18770
Free to view
Prevalence and early detection of myocarditis in idiopathic inflammatory myopathies: a prospective single-centre study
C.R. Calhoun, C.M. Connolly, J. Albayda, E. Tiniakou, C. Mecoli, B. Adler, L. Christopher-Stine, L. Adamo, S.L. Zimmerman, N.N. Gilotra, J. Paik
DOI: https://doi.org/10.55563/clinexprheumatol/2pndb8
C.R. Calhoun, C.M. Connolly, J. Albayda, E. Tiniakou, C. Mecoli, B. Adler, L. Christopher-Stine, L. Adamo, S.L. Zimmerman, N.N. Gilotra, J. Paik
DOI: https://doi.org/10.55563/clinexprheumatol/2pndb8
CER18771
Free to view
Pulmonary nontuberculous mycobacteria disease and anti-neutrophil cytoplasmic antibody positivity: a retrospective analysis of long-term clinical outcomes including vasculitis onset
N. Oda, H. Matsui, N. Oya, T. Suzuki, R. Hazue, R. Rokutanda
DOI: https://doi.org/10.55563/clinexprheumatol/2kjm03
N. Oda, H. Matsui, N. Oya, T. Suzuki, R. Hazue, R. Rokutanda
DOI: https://doi.org/10.55563/clinexprheumatol/2kjm03
CER18777
Free to view
Does different administration method of methotrexate matter in early rheumatoid arthritis? An exploratory register-based study
L. Weman, H. Salo, V. Rantalaiho, J. Huhtakangas, L. Kuusalo, P. Vähäsalo, M. Backström, T. Sokka-Isler
DOI: https://doi.org/10.55563/clinexprheumatol/tg7hxr
L. Weman, H. Salo, V. Rantalaiho, J. Huhtakangas, L. Kuusalo, P. Vähäsalo, M. Backström, T. Sokka-Isler
DOI: https://doi.org/10.55563/clinexprheumatol/tg7hxr
CER18779
Serum NLRC3 levels in systemic lupus erythematosus: correlation with clinical characteristics
W. Li, X. Gu, S. Liu, C. Chen, X. He, B. Huang
DOI: https://doi.org/10.55563/clinexprheumatol/h3m8hl
W. Li, X. Gu, S. Liu, C. Chen, X. He, B. Huang
DOI: https://doi.org/10.55563/clinexprheumatol/h3m8hl
CER19069
The utility of machine learning-based decision support system in referral of suspected rheumatic disease
H. Babaoğlu, H. Satiş, Y. Kavak, A. Tufan
DOI: https://doi.org/10.55563/clinexprheumatol/31phae
H. Babaoğlu, H. Satiş, Y. Kavak, A. Tufan
DOI: https://doi.org/10.55563/clinexprheumatol/31phae
CER18609
Free to view
Real-world outcomes of rituximab- and cyclophosphamide-based induction therapy regimens alone and in combination over 24 months in ANCA-associated vasculitis
K. Von Allwörden, S. Klapa, S.C. Werth, A. Leheis, H. Graßhoff, A. Müller, G. Riemekasten, M. Nitschke, D. Thaçi, P. Lamprecht
DOI: https://doi.org/10.55563/clinexprheumatol/cfyh9p
K. Von Allwörden, S. Klapa, S.C. Werth, A. Leheis, H. Graßhoff, A. Müller, G. Riemekasten, M. Nitschke, D. Thaçi, P. Lamprecht
DOI: https://doi.org/10.55563/clinexprheumatol/cfyh9p
CER19236
Free to view
Illness perception as a determinant of medication adherence in adult Turkish patients with familial Mediterranean fever
S. Yilmaz-Oner, N. Sen, S. Acer Kasman, D. Sahin, N.N. Uzun, S. Osken, O. Volkan, C. Oner, M.E. Tezcan
DOI: https://doi.org/10.55563/clinexprheumatol/z97by2
S. Yilmaz-Oner, N. Sen, S. Acer Kasman, D. Sahin, N.N. Uzun, S. Osken, O. Volkan, C. Oner, M.E. Tezcan
DOI: https://doi.org/10.55563/clinexprheumatol/z97by2
CER19063
Free to view
Health-related quality of life improvements and response thresholds of myositis outcome measures and response criteria
M. Almackenzie, A. Aggarwal, S. Keret, T. Chandra, R. Lomanto Silva, E. Gkiaouraki, N. Pongtarakulpanit, S. Moghadam-Kia, C.V. Oddis, R. Aggarwal
DOI: https://doi.org/10.55563/clinexprheumatol/zcooap
M. Almackenzie, A. Aggarwal, S. Keret, T. Chandra, R. Lomanto Silva, E. Gkiaouraki, N. Pongtarakulpanit, S. Moghadam-Kia, C.V. Oddis, R. Aggarwal
DOI: https://doi.org/10.55563/clinexprheumatol/zcooap
CER19339
Drug-induced osteoporosis/osteopenia: a pharmacovigilance analysis using the FDA Adverse Event Reporting System database
Y. Wang, G. Huang, X. Fu, Z. Wang, W. Mao, G. Zheng
DOI: https://doi.org/10.55563/clinexprheumatol/9vqg6f
Y. Wang, G. Huang, X. Fu, Z. Wang, W. Mao, G. Zheng
DOI: https://doi.org/10.55563/clinexprheumatol/9vqg6f
CER19334
Free to view
Impact of concomitant methotrexate on JAK inhibitors in rheumatoid arthritis-associated interstitial lung disease: a retrospective single-centre study from the KEIO-RA cohort
K. Suzuki, M. Akiyama, K. Shimanuki, Y. Kaneko
DOI: https://doi.org/10.55563/clinexprheumatol/tiu2h4
K. Suzuki, M. Akiyama, K. Shimanuki, Y. Kaneko
DOI: https://doi.org/10.55563/clinexprheumatol/tiu2h4
CER19322
Coexistence of sarcoidosis and spondyloarthritis: a rare but intriguing association
A. Alunno, F. Carubbi, B. De Escalante, G. Policarpo, S. Retamozo, J.S. García Morillo, A. Robles, F. Atzeni, J. Ballano, R. Gómez De La Torre, J.M. Lopez Dupla, M. Ramos-Casals, P. Brito-Zerón
on behalf of the Sjögren Big Data Consortium and the Sarco-GEAS-SEMI Registry
DOI: https://doi.org/10.55563/clinexprheumatol/s678e6
A. Alunno, F. Carubbi, B. De Escalante, G. Policarpo, S. Retamozo, J.S. García Morillo, A. Robles, F. Atzeni, J. Ballano, R. Gómez De La Torre, J.M. Lopez Dupla, M. Ramos-Casals, P. Brito-Zerón
on behalf of the Sjögren Big Data Consortium and the Sarco-GEAS-SEMI Registry
DOI: https://doi.org/10.55563/clinexprheumatol/s678e6
CER19292
Upadacitinib in psoriatic arthritis with prior TNF-inhibitor failure: a 56-week real-world study
U. Bakay, T. Izci Duran, O.S. Karstarli Bakay
DOI: https://doi.org/10.55563/clinexprheumatol/gniy9i
U. Bakay, T. Izci Duran, O.S. Karstarli Bakay
DOI: https://doi.org/10.55563/clinexprheumatol/gniy9i
CER19271
Thirsty eyes: a look at dry eyes in autoimmune/inflammatory syndrome induced by adjuvants
J. Wowk, C. Van Eeden, D. Redmond, M. Osman, J.W. Cohen Tervaert
DOI: https://doi.org/10.55563/clinexprheumatol/h73rbn
J. Wowk, C. Van Eeden, D. Redmond, M. Osman, J.W. Cohen Tervaert
DOI: https://doi.org/10.55563/clinexprheumatol/h73rbn
CER19054
MXRA5 is identified and validated as a key gene related to epithelial-mesenchymal transition in rheumatoid arthritis fibroblast-like synoviocytes
H. Lv, Y. Li, R. Wang, Y. Gao
DOI: https://doi.org/10.55563/clinexprheumatol/dt5mf6
H. Lv, Y. Li, R. Wang, Y. Gao
DOI: https://doi.org/10.55563/clinexprheumatol/dt5mf6
CER19254
Ultrasensitive serum interleukin-8 levels show no association with disease activity or autoantibody profile but relate to cardiovascular comorbidity in systemic lupus erythematosus
M.Á. González-Gay, F. Gómez-Bernal, E. Heras-Recuero, J.C. Quevedo-Abeledo, A. De vera-González, B. Tejera-Segura, C. Gómez-Moreno, E. García-Barrera, L.M. Villar, J.G. Ocejo-Vinyals, R. Largo, I. Ferraz-Amaro
DOI: https://doi.org/10.55563/clinexprheumatol/jgz1oz
M.Á. González-Gay, F. Gómez-Bernal, E. Heras-Recuero, J.C. Quevedo-Abeledo, A. De vera-González, B. Tejera-Segura, C. Gómez-Moreno, E. García-Barrera, L.M. Villar, J.G. Ocejo-Vinyals, R. Largo, I. Ferraz-Amaro
DOI: https://doi.org/10.55563/clinexprheumatol/jgz1oz
CER19220
Patient clustering by serum inflammatory mediators stratifies early disease-modifying antirheumatic drug-naïve rheumatoid arthritis and reveals distinct pathobiological signatures: a prospective observational cohort
G. Kidoguchi, M. Ishitoku, N. Oka, H. Kobayashi, Y. Hosokawa, T. Sugimoto, Y. Yoshida, S. Mokuda, S. Hirata
DOI: https://doi.org/10.55563/clinexprheumatol/bx6ql2
G. Kidoguchi, M. Ishitoku, N. Oka, H. Kobayashi, Y. Hosokawa, T. Sugimoto, Y. Yoshida, S. Mokuda, S. Hirata
DOI: https://doi.org/10.55563/clinexprheumatol/bx6ql2
CER19192
Parvovirus B19 infection with rheumatologic manifestations: results from a multicentre Italian study
F. Aldegheri, R. Bixio, A. Volpe, A. Giollo, M. Fornaro, A. Morciano, M. Orlandi, C. Benini, A. Biglia, E. Bozzalla Cassione, A. Ortolan, D. Bertelle, G. Orsolini, F. Ruzzon, M. Salvato, A. Carletto, F. Campanaro, E. Chessa, E. Fracassi, I. Galvagni, G. Adami
DOI: https://doi.org/10.55563/clinexprheumatol/p64ofs
F. Aldegheri, R. Bixio, A. Volpe, A. Giollo, M. Fornaro, A. Morciano, M. Orlandi, C. Benini, A. Biglia, E. Bozzalla Cassione, A. Ortolan, D. Bertelle, G. Orsolini, F. Ruzzon, M. Salvato, A. Carletto, F. Campanaro, E. Chessa, E. Fracassi, I. Galvagni, G. Adami
DOI: https://doi.org/10.55563/clinexprheumatol/p64ofs
CER19174
Clinical significance of serum IgE/IgG4 ratio in patients with IgG4-related disease
O.C. Kwon, Y.-B. Park, K.H. Park, S.-W. Lee
DOI: https://doi.org/10.55563/clinexprheumatol/aus9qq
O.C. Kwon, Y.-B. Park, K.H. Park, S.-W. Lee
DOI: https://doi.org/10.55563/clinexprheumatol/aus9qq
CER19121
Carotid vasa vasorum detected by super-resolution ultrasound microvascular imaging in Takayasu’s arteritis: a potential biomarker of disease activity and early treatment outcome
P. Cong, C.-X. Li, C.-K. Zhao, T.-T. Fu, P. Sun, K.-L. Chen, Y.-L. Zhu, Y.-Q. Zhang, D. Lu, Y.-W. Luo, S.-J. You, L.-Y. Ma, L.-D. Jiang, H. Han, H.-X. Xu
DOI: https://doi.org/10.55563/clinexprheumatol/zbn37g
P. Cong, C.-X. Li, C.-K. Zhao, T.-T. Fu, P. Sun, K.-L. Chen, Y.-L. Zhu, Y.-Q. Zhang, D. Lu, Y.-W. Luo, S.-J. You, L.-Y. Ma, L.-D. Jiang, H. Han, H.-X. Xu
DOI: https://doi.org/10.55563/clinexprheumatol/zbn37g
CER19107
Free to view
Clinical practice guidelines for reporting nail fold videocapillaroscopy: a Delphi consensus on behalf of the Italian Society of Rheumatology study group on capillaroscopy
F. Ingegnoli, D. Pireddu, E. Platania, R. De Angelis, A. Alunno, A. Ariani, S. Barsotti, V. Batani, L. Belloli, A. Bezzi, S.L. Bosello, F. Cacciapaglia, S.L. Calvisi, N. Carlo-Stella, F. Carubbi, I. Cavazzana, V. Codullo, M. Colaci, M. Cornalba, G. Cuomo, G. De Marchi, A. Della Rossa, M. Di Battista, E. Di Ruscio, P. Faggioli, M. Favero, R. Foti, F. Girelli, D. Giuggioli, S. Guiducci, E. Gotelli, V. Grosso, E. Hysa, A. Iuliano, F. Lalli, L. Leveghi, E. Marasco, G. Mennillo, G. Moroncini, G. Pellegrino, C. Perricone, C. Pizzorni, E. Praino, L. Quarta, V.L. Ramoni, L. Santo, C. Schenone, M. Sebastiani, L. Serafino, T. Serban, P. Stobbione, A. Sulli, S. Truglia, V. Smith, M. Cutolo, V. Riccieri
On behalf of the Study Group on Capillaroscopy and Microcirculation in Rheumatic Diseases of the Italian Society of Rheumatology (CAPSIR)
DOI: https://doi.org/10.55563/clinexprheumatol/2z4j95
F. Ingegnoli, D. Pireddu, E. Platania, R. De Angelis, A. Alunno, A. Ariani, S. Barsotti, V. Batani, L. Belloli, A. Bezzi, S.L. Bosello, F. Cacciapaglia, S.L. Calvisi, N. Carlo-Stella, F. Carubbi, I. Cavazzana, V. Codullo, M. Colaci, M. Cornalba, G. Cuomo, G. De Marchi, A. Della Rossa, M. Di Battista, E. Di Ruscio, P. Faggioli, M. Favero, R. Foti, F. Girelli, D. Giuggioli, S. Guiducci, E. Gotelli, V. Grosso, E. Hysa, A. Iuliano, F. Lalli, L. Leveghi, E. Marasco, G. Mennillo, G. Moroncini, G. Pellegrino, C. Perricone, C. Pizzorni, E. Praino, L. Quarta, V.L. Ramoni, L. Santo, C. Schenone, M. Sebastiani, L. Serafino, T. Serban, P. Stobbione, A. Sulli, S. Truglia, V. Smith, M. Cutolo, V. Riccieri
On behalf of the Study Group on Capillaroscopy and Microcirculation in Rheumatic Diseases of the Italian Society of Rheumatology (CAPSIR)
DOI: https://doi.org/10.55563/clinexprheumatol/2z4j95
CER19080
Free to view
Modification of 2022 ACR/EULAR ANCA-associated vasculitis classification criteria in a Japanese cohort (J-CANVAS)
N. Tanaka-Mabuchi, T. Kida, S. Hanai, Y. Kobayashi, S. Omura, Y. Abe, M. Kadoya, N. Takizawa, A. Nomura, Y. Kukida, N. Kondo, Y. Yamano, T. Yanagida, K. Endo, S. Hirata, K. Matsui, T. Takeuchi, K. Ichinose, M. Kato, R. Yanai, Y. Matsuo, Y. Shimojima, R. Nishioka, R. Okazaki, T. Takata, T. Ito, M. Moriyama, A. Takatani, Y. Miyawaki, N. Yajima, T. Ito-Ihara, T. Kawaguchi, Y. Kawahito, D. Nakagomi
DOI: https://doi.org/10.55563/clinexprheumatol/5naes7
N. Tanaka-Mabuchi, T. Kida, S. Hanai, Y. Kobayashi, S. Omura, Y. Abe, M. Kadoya, N. Takizawa, A. Nomura, Y. Kukida, N. Kondo, Y. Yamano, T. Yanagida, K. Endo, S. Hirata, K. Matsui, T. Takeuchi, K. Ichinose, M. Kato, R. Yanai, Y. Matsuo, Y. Shimojima, R. Nishioka, R. Okazaki, T. Takata, T. Ito, M. Moriyama, A. Takatani, Y. Miyawaki, N. Yajima, T. Ito-Ihara, T. Kawaguchi, Y. Kawahito, D. Nakagomi
DOI: https://doi.org/10.55563/clinexprheumatol/5naes7
CER19077
Free to view
Factors associated with endomysial fibrosis in anti-signal recognition particle antibody immune-mediated necrotising myopathy
J. Yuan, M. Yang, Y. Zheng, H. Hao, F. Gao, W. Zhang, Z. Wang, Y. Yuan, Y. Zhao
DOI: https://doi.org/10.55563/clinexprheumatol/bzpse1
J. Yuan, M. Yang, Y. Zheng, H. Hao, F. Gao, W. Zhang, Z. Wang, Y. Yuan, Y. Zhao
DOI: https://doi.org/10.55563/clinexprheumatol/bzpse1
CER19075
Free to view
Alterations of mucosal-associated invariant T cells in dermatomyositis
S. Ye, J. Du, Y. Zhang, W. Wei, Y. Li
DOI: https://doi.org/10.55563/clinexprheumatol/vp3uim
S. Ye, J. Du, Y. Zhang, W. Wei, Y. Li
DOI: https://doi.org/10.55563/clinexprheumatol/vp3uim
CER19270
Free to view
Potential clinical utility of quantitative 18F-FDG PET/CT parameters in evaluating vascular inflammation in giant cell arteritis
C. Ricordi, R. Durmo, P. Giorgi Rossi, C. Salvarani, A. Versari, A. Filice, G.G. Hunder, F. Muratore, C. Marvisi
DOI: https://doi.org/10.55563/clinexprheumatol/4v576r
C. Ricordi, R. Durmo, P. Giorgi Rossi, C. Salvarani, A. Versari, A. Filice, G.G. Hunder, F. Muratore, C. Marvisi
DOI: https://doi.org/10.55563/clinexprheumatol/4v576r
Review
CER18776
Research progress of NLRP3 in immune cells of systemic lupus erythematosus
Y. Liu, Y. Wang, X. Wang, Y. Liu, Y. Wang
DOI: https://doi.org/10.55563/clinexprheumatol/xmghi4
Y. Liu, Y. Wang, X. Wang, Y. Liu, Y. Wang
DOI: https://doi.org/10.55563/clinexprheumatol/xmghi4
CER19138
Intercepting the psoriasis-psoriatic arthritis continuum: a precision-medicine framework for at-risk, subclinical, and early psoriatic arthritis
F. Caso, M. Cascone, N. Girolimetto, M. Megna, F. Maione, A. Saviano, M. Vastarella, M. Tasso, R. Scarpa, R. Giacomelli, P. Ruscitti
DOI: https://doi.org/10.55563/clinexprheumatol/vrplme
F. Caso, M. Cascone, N. Girolimetto, M. Megna, F. Maione, A. Saviano, M. Vastarella, M. Tasso, R. Scarpa, R. Giacomelli, P. Ruscitti
DOI: https://doi.org/10.55563/clinexprheumatol/vrplme
CER19096
Free to view
Efficacy and safety of tocilizumab in polyarteritis nodosa and adenosine deaminase 2 deficiency: a systematic literature review
E.S. Torun, S. Çelen
DOI: https://doi.org/10.55563/clinexprheumatol/477rzo
E.S. Torun, S. Çelen
DOI: https://doi.org/10.55563/clinexprheumatol/477rzo
CER19016
The potential role of neutrophils in connective tissue disease-associated interstitial lung disease
H. Wang, Y. Lu, J. Liu, Z. Sang, W. Fan, Y. Liu, J. Lin
DOI: https://doi.org/10.55563/clinexprheumatol/su8rvb
H. Wang, Y. Lu, J. Liu, Z. Sang, W. Fan, Y. Liu, J. Lin
DOI: https://doi.org/10.55563/clinexprheumatol/su8rvb
CER19185
Free to view
Targeting fibroblast-like synoviocytes with CDK4/6 inhibitors as a novel, non-immunosuppressive treatment strategy for rheumatoid arthritis
D. Baeten, H. Kohsaka, D. Miura
DOI: https://doi.org/10.55563/clinexprheumatol/4fyfje
D. Baeten, H. Kohsaka, D. Miura
DOI: https://doi.org/10.55563/clinexprheumatol/4fyfje
CER18696
Free to view
Non-inflammatory mimickers of myositis: a guide for rheumatologists
S.P. Silva, M. Pinto, D. Costa, A. Azevedo, E. Dourado
DOI: https://doi.org/10.55563/clinexprheumatol/v0joqy
S.P. Silva, M. Pinto, D. Costa, A. Azevedo, E. Dourado
DOI: https://doi.org/10.55563/clinexprheumatol/v0joqy
CER19417
Free to view
IgG4-related prostatitis: expanding the spectrum of IgG4-related disease. A systematic review
C. Pamfil, M.I. Mihon, V. Surdu, C. Bucșa, G. Cabău, L. Damian, I. Felea, T.N. Onea, S. Rednic, R. Talarico
DOI: https://doi.org/10.55563/clinexprheumatol/i8eh4g
C. Pamfil, M.I. Mihon, V. Surdu, C. Bucșa, G. Cabău, L. Damian, I. Felea, T.N. Onea, S. Rednic, R. Talarico
DOI: https://doi.org/10.55563/clinexprheumatol/i8eh4g
CER19372
Free to view
Pain in myositis: prevalence, assessment, potential mechanisms and considerations for management
S. Glaubitz, Y.C. Lee, D. Saygin
S. Glaubitz, Y.C. Lee, D. Saygin
CER18875
Is there place for TNF-alpha inhibitors in the treatment of connective tissue diseases?
A. Matusiewicz, M. Dziewit, S. Ornowska, M. Olesińska
DOI: https://doi.org/10.55563/clinexprheumatol/r24pfo
A. Matusiewicz, M. Dziewit, S. Ornowska, M. Olesińska
DOI: https://doi.org/10.55563/clinexprheumatol/r24pfo
CER18953
Red wine antioxidant properties implications in rheumatic diseases: exploring clonal variations in resveratrol and other bioactive compounds
F. Belli, F. Bandinelli, R. Bandinelli, M. Pagano
DOI: https://doi.org/10.55563/clinexprheumatol/pybjjj
F. Belli, F. Bandinelli, R. Bandinelli, M. Pagano
DOI: https://doi.org/10.55563/clinexprheumatol/pybjjj
Paediatric Rheumatology
CER18814
Free to view
Association of NXP2 autoantibodies with a more severe clinical phenotype of juvenile dermatomyositis
Y. Wang, J. Liang, J. Wang, F. Zheng, L. Teng, Q. Ma, Y. Zhou, L. Liang, J. Lin, M. Lu, H. Cao, X. Xu
DOI: https://doi.org/10.55563/clinexprheumatol/820f4x
Y. Wang, J. Liang, J. Wang, F. Zheng, L. Teng, Q. Ma, Y. Zhou, L. Liang, J. Lin, M. Lu, H. Cao, X. Xu
DOI: https://doi.org/10.55563/clinexprheumatol/820f4x
CER19248
Nailfold videocapillaroscopy in the assessment of juvenile connective tissue diseases
M. Binda, B. Moccaldi, F. Tirelli, V. Sanetti, A. Cuberli, A. Benini, A. Meneghel, R. Ramonda, F. Zulian, E. Zanatta
DOI: https://doi.org/10.55563/clinexprheumatol/6bz7ok
M. Binda, B. Moccaldi, F. Tirelli, V. Sanetti, A. Cuberli, A. Benini, A. Meneghel, R. Ramonda, F. Zulian, E. Zanatta
DOI: https://doi.org/10.55563/clinexprheumatol/6bz7ok
Letters to the Editor
CER18769
Free to view
Undifferentiated spondyloarthritis with late onset large vessel vasculitis and upadacitinib induced remission
N. Ahmed, K.J. Warrington, M.J. Koster
DOI: https://doi.org/10.55563/clinexprheumatol/8ocj7h
N. Ahmed, K.J. Warrington, M.J. Koster
DOI: https://doi.org/10.55563/clinexprheumatol/8ocj7h
CER19390
Free to view
Reply to the comment on: Cancer-associated myositis before and after the COVID-19 pandemic onset
H. Daungsupawong, V. Wiwanitkit
H. Daungsupawong, V. Wiwanitkit
CER19393
Free to view
Upadacitinib in resistant Takayasu's arteritis with coexisting ulcerative colitis
B. Sulu, A. Akpinar, S. Şirolu, L. Uslu Besli, A.F. Çelik, E. Seyahi
DOI: https://doi.org/10.55563/clinexprheumatol/9t7eeg
B. Sulu, A. Akpinar, S. Şirolu, L. Uslu Besli, A.F. Çelik, E. Seyahi
DOI: https://doi.org/10.55563/clinexprheumatol/9t7eeg
CER19189
Free to view
Reply to the comments on: Increased serum soluble interleukin-2 receptor concentrations are linked to high-sensitivity troponin T and disease progression in systemic sclerosis
S. Klapa, L. Schumacher, P. Lamprecht
on behalf of all authors.
DOI: https://doi.org/10.55563/clinexprheumatol/eaaqk8
S. Klapa, L. Schumacher, P. Lamprecht
on behalf of all authors.
DOI: https://doi.org/10.55563/clinexprheumatol/eaaqk8
CER19130
Free to view
Comments on: Increased serum soluble interleukin-2 receptor concentrations are linked to high-sensitivity troponin T and disease progression in systemic sclerosis
G. Chen, L.M. Zhang, Y. Zhang
DOI: https://doi.org/10.55563/clinexprheumatol/5ynhsh
G. Chen, L.M. Zhang, Y. Zhang
DOI: https://doi.org/10.55563/clinexprheumatol/5ynhsh
CER19092
Free to view
Successful use of upadacitinib in a 14-year-old patient with juvenile idiopathic arthritis-associated uveitis and hidradenitis suppurativa
S. Romano, C. De Libero, E. Marrani, G. Simonini, I. Maccora
DOI: https://doi.org/10.55563/clinexprheumatol/ot85sk
S. Romano, C. De Libero, E. Marrani, G. Simonini, I. Maccora
DOI: https://doi.org/10.55563/clinexprheumatol/ot85sk
CER19067
Free to view
Comment on: Successful management of pulmonary hypertension with baricitinib in a dermatomyositis patient
C. Pinto Oliveira, M.D. Pascoal, A.R. Prata, D. Carvalho, M.G. Castro, E. Dourado
DOI: https://doi.org/10.55563/clinexprheumatol/jk5vx1
C. Pinto Oliveira, M.D. Pascoal, A.R. Prata, D. Carvalho, M.G. Castro, E. Dourado
DOI: https://doi.org/10.55563/clinexprheumatol/jk5vx1
CER18967
Free to view
Comment on: Triple-combination therapy did not improve prognosis in anti-MDA5 positive dermatomyositis: a multicentre longitudinal cohort study by You et al.
W. Rojas-Zuleta
DOI: https://doi.org/10.55563/clinexprheumatol/spyyh8
W. Rojas-Zuleta
DOI: https://doi.org/10.55563/clinexprheumatol/spyyh8
CER18960
Free to view
Synovial biopsy in a case of nivolumab-induced arthritis
R. Pereira Da Costa, M. Pinho, J. Patrocínio, S. Torres, C. Ferreira, J.E. Fonseca, N. Khmelinskii
DOI: https://doi.org/10.55563/clinexprheumatol/2z7vho
R. Pereira Da Costa, M. Pinho, J. Patrocínio, S. Torres, C. Ferreira, J.E. Fonseca, N. Khmelinskii
DOI: https://doi.org/10.55563/clinexprheumatol/2z7vho
CER18791
Free to view
Successful therapy of refractory dermatomyositis skin rash with anifrolumab
C. Galluzzo, N. Pipitone, I. Chiapparoli, C. Salvarani
DOI: https://doi.org/10.55563/clinexprheumatol/haftre
C. Galluzzo, N. Pipitone, I. Chiapparoli, C. Salvarani
DOI: https://doi.org/10.55563/clinexprheumatol/haftre
CER19227
Free to view
Reply to the comment on: Successful management of pulmonary hypertension with baricitinib in a dermatomyositis patient
C. Rizzo, L. La Barbera, G. Guggino
DOI: https://doi.org/10.55563/clinexprheumatol/g129j4
C. Rizzo, L. La Barbera, G. Guggino
DOI: https://doi.org/10.55563/clinexprheumatol/g129j4
CER19357
Free to view
Resolution of refractory systemic lupus erythematosus-associated alopecia with anifrolumab: a case report
G. Buscetta, C. Rizzo, G. Guggino
DOI: https://doi.org/10.55563/clinexprheumatol/udjhxr
G. Buscetta, C. Rizzo, G. Guggino
DOI: https://doi.org/10.55563/clinexprheumatol/udjhxr
CER18908
Free to view
Dermatomyositis assessment of rash via telemedicine: a prospective study
N. Pongtarakulpanit, A. Bishnoi, D.P. Ascherman, S. Moghadam-Kia, C.V. Oddis, R. Aggarwal
DOI: https://doi.org/10.55563/clinexprheumatol/g16i0y
N. Pongtarakulpanit, A. Bishnoi, D.P. Ascherman, S. Moghadam-Kia, C.V. Oddis, R. Aggarwal
DOI: https://doi.org/10.55563/clinexprheumatol/g16i0y
Environmental Rheumatology
CER19352
Free to view
Comparison of pre- and post-natal environmental exposures in United States versus Brazilian patients with juvenile dermatomyositis
T.M. Arabi, S.C. Farhat, C.C. Valoes, S. Shenoi, S. Kim, B.O. Carneiro, L.G. Rider, A.M. Elias
DOI: https://doi.org/10.55563/clinexprheumatol/d72tz5
T.M. Arabi, S.C. Farhat, C.C. Valoes, S. Shenoi, S. Kim, B.O. Carneiro, L.G. Rider, A.M. Elias
DOI: https://doi.org/10.55563/clinexprheumatol/d72tz5